Skip to Content List

  • Skip to primary content
  • Skip to footer content

Site Navigation Lists

  • Fellowship Application
  • Grantmaking Process
  • Contact Us
  • About
    • Mission and Vision
    • Staff
    • Board
    • Leadership Council
    • Impact Reports
    • Impact Photo Series
  • Programs and Impact
    • Our Programs and Impact
    • Education and Youth Development
    • Criminal and Juvenile Justice
    • Addiction and Health Equity
    • Community Fellowships
  • Grantees and Fellows
    • Grantee Database
    • Grantmaking Process
    • Community Fellows
    • How to Apply
  • News and Reports
    • Baltimore Justice Report
    • Newsletters
    • Reports
    • Impact Reports
    • Blueprint for Baltimore
    • OSI in the News
  • Events
    • Upcoming Events
    • Past Events
    • 20th Anniversary Speaker Series
    • Talking About Race Series
    • Talking About Addiction Series
  • Privacy
  • Cookie Policy
  • Community Guidelines
  • Terms & Conditions
Open Society Institute – Baltimore

Open Society Institute – Baltimore

Open Society Institute (OSI) – Baltimore : Audacious Thinking For Lasting Change

  • Fellowship Application
  • Grantmaking Process
  • Contact Us
  • EN
    • EN
    • ES
  • About
    • Mission and Vision
    • Staff
    • Board
    • Leadership Council
    • Impact Reports
    • Impact Photo Series
  • Programs and Impact
    • Our Programs and Impact
    • Education and Youth Development
    • Criminal and Juvenile Justice
    • Addiction and Health Equity
    • Community Fellowships
  • Grantees and Fellows
    • Grantee Database
    • Grantmaking Process
    • Community Fellows
    • How to Apply
  • News and Reports
    • Baltimore Justice Report
    • Newsletters
    • Reports
    • Impact Reports
    • Blueprint for Baltimore
    • OSI in the News
  • Events
    • Upcoming Events
    • Past Events
    • 20th Anniversary Speaker Series
    • Talking About Race Series
    • Talking About Addiction Series
Changes in Medicaid treatment options puts patients in danger

Featured in
Baltimore Justice Report

Next Article
OSI Celebrates opening of grantee Positive Schools Center

Baltimore Justice Report

Changes in Medicaid treatment options puts patients in danger

Monday, July 18, 2016

Content Social Share Links

  • Share on Facebook
  • Share on Twitter

This weekend, Baltimore Sun highlighted on its front page the potential problems in recent changes to the Maryland Medicaid Pharmacy Preferred Drug List (PDL), issues that Scott Nolen, director of OSI-Baltimore’s Drug Addiction Treatment program and others raised in a June 23rd op-ed in the Sun.

On July 1, the Department of Health and Mental Hygiene (DHMH) removed Suboxone film (also known as buprenorphine film), an effective and well-tolerated medication that is widely prescribed to treat opioid addiction, from the PDL and replaced it with Zubsolv tablets, citing, among other reasons, efforts to counter the smuggling of the film into Maryland correctional facilities.

Nolen and co-authors Deborah Agus, executive director of Behavioral Health Leadership Institute (BHLI), and Dr. Leonard Feldman, associate professor of internal medicine and pediatrics at the Johns Hopkins School of Medicine and president of BHLI’s board, contend that this change will be a “major barrier” for many who have struggled with addiction. “The new medication might not work as well for them. Dosages will need adjustment. For many patients in early recovery, recovery is tenuous… There is a real possibility that many will fail to make the transition; they will join the ever increasing overdose death statistics in Maryland.”

Dr. Leana Wen, Baltimore’s health commissioner, seems to agree. In a letter to Van T. Mitchell, secretary of the state Department of Health and Mental Hygiene, she wrote, “Changes in medication formulation can and will lead to relapses, overdoses and deaths.”

The Sun also notes that DHMH Secretary Van Mitchell’s former employer, the lobbying firm Manis Canning & Associates, represents Orexo US Inc., Zubsolv’s maker, raising the possibility of a conflict of interest.

 

OSI-Baltimore is committed to addressing the public health crisis of addiction and has been working for nearly a decade to make buprenorphine widely available to treat opiate addiction in Baltimore, as detailed in our recent report, “Using Buprenorphine to Treat Opioid Addiction.”

Related Content

The Sun’s Justin George on the underpinnings of crime

Baltimore Sun crime reporter Justin George is interviewed in this Q and A from the Trace. George recognizes that the issues o…

Read More

Post navigation

Previous Article Previous Congress approves $181 million for addiction and recovery response
Next Article Next Article OSI Celebrates opening of grantee Positive Schools Center
  • Facebook
  • Instagram
  • Twitter
  • Youtube

Subscribe to our mailing list

OSI Logo

Open Society Institute-Baltimore
Bold Thinking, Strategic Action, Justice for All.

© 2025 Open Society Institute-Baltimore
  • Privacy
  • Cookie Policy
  • Community Guidelines
  • Terms & Conditions

OSI-Baltimore has permanently closed. It has been our honor and privilege to partner with and serve the Baltimore community for the past 25 years.

This website is available for historical purposes.  It is no longer being updated.

Skip to top of page